Pfizer Inc (NYSE:PFE) shares are moving higher Tuesday following multiple developments. Here's a look at what's going on.

Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

When companies post strong earnings, the stock generally performs well, just like Pfizer Inc.'s ( NYSE:PFE ) stock ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

But I actually see this as a risk factor since according to my earlier analysis, Pfizer ... company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is ...

Last year was a strong one in terms of performance and execution by Pfizer, even though its stock took a hit in 2023 due to a decline in revenues and profits. It saw improved performance of its ...

Pfizer’s PFE $13.7 billion in revenue (an ... Management said that full-year performance is trending toward the high end of EPS guidance. Cardiomyopathy drugs including Vyndaqel grew 31% ...

Here is some historical data on the past post-earnings performance of Pfizer stock compared with the stock performance of peers that reported earnings just before Pfizer. For fair comparison ...

Below is some historical data on the post-earnings performance of Pfizer stock compared to the stock performance of peers that reported their earnings just before Pfizer. For a fair comparison ...